CF Benchmarks’ Weekly Index Highlights, our series of concise crypto market summaries, was launched in early September, 2024.
Many market professionals have already discovered the benefits of having a trustworthy go-to source of unbiased commentary to hand every Monday, to quickly get up to speed with how digital assets fared the previous week.
And because their cadence is weekly, the highlights are easy to integrate into analyses of the broader market context institutional participants typically keep abreast of already.
Naturally, these weekly reports showcase CF Benchmarks’ high-integrity rules-based methodology; spanning single asset indices covering Bitcoin, Ethereum, Solana, Ripple and other large caps (the CME CF Single Asset Series); portfolios measuring whole market beta (the CF Capitalization Series); and indices focused more specifically on blockchain thematics (the CF Classification Series).
All told, our Weekly Index Highlights (WIH) are the only high frequency, quickly digestible read on cryptocurrency markets from a regulated Benchmark Administrator.
It's also worth noting Weekly Index Highlights are an integral part of CF Benchmarks’ complete research and content portfolio.
Our product, research and content teams have established a broad suite of publications, with each intended to supplement to the sum of the parts.
This enables a credible and comprehensive view of the investible digital asset market.
Below, we spotlight 5 key ways Weekly Index Highlights integrate into CF Benchmarks' broader suite of research content, providing an invaluable addition to any market monitoring routine.
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
CF Benchmarks